Product Information
CLOBETASOL 0.05% OINTMENT is a generic product labeled by Encube Ethicals, Inc., priced at $0.1545 per GM under NDC 21922001705. Its NADAC has been published 354 times since Feb 5, 2020.
FDA first approved this application on Nov 15, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/g
Manufacturer
Encube Ethicals, Inc.NDC
21922001705
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
10/21/2026
Active Ingredients
CLOBETASOL PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA211295FDA Approved
11/15/2019
TE Code
AB
On Market Since
11/18/2019
Pharmacological Classes
Price Statistics
The NADAC for CLOBETASOL 0.05% OINTMENT has been published 354 times since Feb 5, 2020, and over the history we have for it it has declined 74.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1545 per GM |
|---|---|
| All-time high | $0.6473 (Apr 15, 2020) |
| All-time low | $0.1196 (Nov 20, 2024) |
| 52-week high | $0.1749 |
| 52-week low | $0.1533 |
| Median price | $0.2142 |
| Average price | $0.3021 |
| Largest weekly change | -40.1% (Nov 20, 2024) |
| Weeks tracked | 354 |
| Tracking since | Feb 5, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Encube Ethicals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clobetasol Propionate Ointment USP, 0.05% market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOBETASOL 0.05% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for CLOBETASOL 0.05% OINTMENT, manufactured by Encube Ethicals, Inc., is $0.1545 per GM (NDC 21922001705), effective Nov 11, 2026.
How has the price of CLOBETASOL 0.05% OINTMENT changed over time?
Over the history we have for it, the NADAC for CLOBETASOL 0.05% OINTMENT has declined 74.7%. It has been tracked across 354 weekly CMS publications since Feb 5, 2020.
What are the highest and lowest recorded NADAC prices for CLOBETASOL 0.05% OINTMENT?
Since Feb 5, 2020, the NADAC for CLOBETASOL 0.05% OINTMENT has ranged from a low of $0.1196 (Nov 20, 2024) to a high of $0.6473 (Apr 15, 2020), with a median of $0.2142 per GM.
Are there cheaper alternatives to CLOBETASOL 0.05% OINTMENT?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOBETASOL 0.05% OINTMENT, is $0.1130 per GM — about 27% below CLOBETASOL 0.05% OINTMENT.
Who manufactures CLOBETASOL 0.05% OINTMENT?
CLOBETASOL 0.05% OINTMENT (NDC 21922001705) is labeled by Encube Ethicals, Inc., and CMS classifies it as a generic product.